Myleran

In some countries, this medicine may only be approved for veterinary use.

In the US, Myleran (busulfan systemic) is a member of the drug class alkylating agents and is used to treat Bone Marrow Transplantation, Chronic Myelogenous Leukemia and Thrombocythemia.

US matches:

• Myleran

UK matches:

• Myleran Tablets 2mg
• Myleran film coated tablets 2mg (SPC)

Ingredient matches for Myleran

Busulfan

Busulfan is reported as an ingredient of Myleran in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Belgium


• Brazil


• Canada


• Chile


• Czech Republic


• Egypt


• Estonia


• Ethiopia


• France


• Germany


• Guyana


• Hong Kong


• Iceland


• India


• Iran


• Iraq


• Ireland


• Israel


• Italy


• Jordan


• Kuwait


• Lebanon


• Lithuania


• Luxembourg


• Mexico


• Netherlands


• New Zealand


• Oman


• Poland


• Portugal


• Qatar


• Romania


• Russian Federation


• Saudi Arabia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Sweden


• Syria


• Taiwan


• Thailand


• Turkey


• United Arab Emirates


• United Kingdom


• United States


• Yemen

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.